Total Payments
$4,486
2024 Payments
$462.66
Companies
43
Transactions
249
Medicare Patients
185
Medicare Billing
$8,134
Payment Breakdown by Category
Food & Beverage$4,302 (95.9%)
Education$184.35 (4.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,302 | 237 | 95.9% |
| Education | $184.35 | 12 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $645.76 | 32 | $0 (2023) |
| PFIZER INC. | $483.84 | 47 | $0 (2023) |
| Medtronic, Inc. | $394.84 | 4 | $0 (2024) |
| ABBVIE INC. | $308.12 | 18 | $0 (2022) |
| TherapeuticsMD, Inc. | $187.92 | 16 | $0 (2022) |
| Smith+Nephew, Inc. | $180.30 | 9 | $0 (2023) |
| Myovant Sciences Inc. | $178.83 | 10 | $0 (2022) |
| Astellas Pharma US Inc | $165.57 | 7 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $150.59 | 10 | $0 (2019) |
| Integra LifeSciences Corporation | $150.50 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.66 | 18 | Medtronic, Inc. ($160.47) |
| 2023 | $518.93 | 14 | Integra LifeSciences Corporation ($150.50) |
| 2022 | $905.17 | 39 | Medtronic, Inc. ($234.37) |
| 2021 | $691.97 | 44 | TherapeuticsMD, Inc. ($128.99) |
| 2020 | $271.33 | 17 | Bayer HealthCare Pharmaceuticals Inc. ($98.71) |
| 2019 | $331.01 | 22 | Smith+Nephew, Inc. ($63.46) |
| 2018 | $639.29 | 40 | Bayer HealthCare Pharmaceuticals Inc. ($124.36) |
| 2017 | $665.49 | 55 | PFIZER INC. ($252.90) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.26 | General |
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Biological | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: HORMONE THERAPY | ||||||
| 10/21/2024 | Medtronic, Inc. | V-LOC 180 (Device) | Food and Beverage | In-kind items and services | $139.19 | General |
| Category: Wound Closure | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Biological | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: HORMONE THERAPY | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Biological | ||||||
| 09/05/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: HORMONE THERAPY | ||||||
| 07/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Bone Health | ||||||
| 06/18/2024 | Medtronic, Inc. | TRUCLEAR (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Hysteroscopy Systems | ||||||
| 05/29/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Biological | ||||||
| 03/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Biological | ||||||
| 03/06/2024 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 02/20/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 11/29/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Biological | ||||||
| 10/24/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena, Skyla | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Womens Health | ||||||
| 09/28/2023 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $19.52 | General |
| 08/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Womens Health | ||||||
| 07/24/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $88.96 | General |
| Category: Urology | ||||||
| 06/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Womens Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 47 | $8,748 | $2,294 |
| 2022 | 1 | 30 | 30 | $5,220 | $1,215 |
| 2021 | 2 | 55 | 55 | $9,894 | $2,292 |
| 2020 | 2 | 54 | 54 | $9,814 | $2,333 |
Total Patients
185
Total Services
186
Medicare Billing
$8,134
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 32 | 32 | $5,568 | $1,277 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $3,180 | $1,016 | 32.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 30 | 30 | $5,220 | $1,215 | 23.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 43 | 43 | $7,482 | $1,751 | 23.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 12 | 12 | $2,412 | $541.20 | 22.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 43 | 43 | $7,482 | $1,773 | 23.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $2,332 | $560.42 | 24.0% |
About Dr. Mae Borchardt, M.D
Dr. Mae Borchardt, M.D is a Obstetrics & Gynecology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1255651725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mae Borchardt, M.D has received a total of $4,486 in payments from pharmaceutical and medical device companies, with $462.66 received in 2024. These payments were reported across 249 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($4,302).
As a Medicare-enrolled provider, Borchardt has provided services to 185 Medicare beneficiaries, totaling 186 services with total Medicare billing of $8,134. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Houston, TX
- Active Since 06/08/2010
- Last Updated 03/17/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255651725
Products in Payments
- Kyleena (Drug) $443.14
- V-LOC 180 (Device) $373.56
- LO LOESTRIN FE (Drug) $281.56
- MYFEMBREE (Drug) $260.94
- PREMARIN ORALS (Drug) $230.14
- Mirena (Drug) $202.62
- ANNOVERA (Drug) $174.50
- Veozah (Drug) $165.57
- PREMARIN (Drug) $161.44
- Integra (Device) $150.50
- RS Harmony Test Related Products (Device) $114.76
- INTRAROSA (Drug) $105.47
- DIVIGEL (Drug) $95.00
- Axonics (Device) $88.96
- NEXPLANON (Drug) $88.92
- Balcoltra (Drug) $88.46
- SLYND (Drug) $76.17
- PICO (Device) $68.49
- INJECTAFER (Drug) $66.04
- PICO Single Use Negative Pressure Wound Therapy (Device) $63.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Houston
Dr. George Kuhn, Md, MD
Obstetrics & Gynecology — Payments: $241,556
Obstetrics & Gynecology $241,556
Shannon Westin, Md, MD
Obstetrics & Gynecology — Payments: $166,777
Obstetrics & Gynecology $166,777
Sandra Hurtado, M.d, M.D
Obstetrics & Gynecology — Payments: $160,121
Obstetrics & Gynecology $160,121
Baha Sibai, M.d, M.D
Obstetrics & Gynecology — Payments: $130,256
Obstetrics & Gynecology $130,256
Jimmy Espinoza, M.d, M.D
Obstetrics & Gynecology — Payments: $108,379
Obstetrics & Gynecology $108,379
Nicole Tran, Md, MD
Obstetrics & Gynecology — Payments: $104,647
Obstetrics & Gynecology $104,647